Contact

Oct 5 2011 3:24 PM

Champions Oncology, Inc.

Main Offices:

Phone: 201-808-8400
Toll Free: 866-746-5457

Science & Technology:

Phone: 410-369-0365
Toll Free: 866-746-5457
Fax: 410-369-0390

Media Inquiries:

Phone: 201-808-8480
E-mail: [email protected]

Champions Oncology UK Ltd.

London BioScience Innovation Centre
2 Royal College Street
London NW1 0NH
United Kingdom
Tel: +44 (0)20 7691 4925

Champions Oncology (Israel) Ltd.

17 HaTidhar Street, 2nd Floor
PO Box 4109
Ra’anana, Israel 43100

Send us an e-mail:

1. What are you inquiring about?

Cancer treatment options

Translational Oncology Solutions

Media Inquiries

Something else

References:

Hidalgo M et al. Activity of gemcitabine in direct patient derived xenografts predicts clinical outcome: validation of an in vivo model for drug development. J Clin Oncol 27:15s, 2009 (suppl; abstr 4528)
Hidalgo M et al. A Pilot Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer. Mol Cancer Ther August 2011 10:1311-1316
Rubio-Viqueira B, Jimeno A, Cusatis G, et al. An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res. 2006;12:4652-4661.
Champions data on file.